Cargando…
Inhibition of polymerase chain reaction: Pathogen-specific controls are better than human gene amplification
PCR inhibition is frequent in medical microbiology routine practice and may lead to false-negative results; however there is no consensus on how to detect it. Pathogen-specific and human gene amplifications are widely used to detect PCR inhibition. We aimed at comparing the value of PCR inhibitor de...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764677/ https://www.ncbi.nlm.nih.gov/pubmed/31560697 http://dx.doi.org/10.1371/journal.pone.0219276 |
_version_ | 1783454425700892672 |
---|---|
author | Roux, Guillaume Ravel, Christophe Varlet-Marie, Emmanuelle Jendrowiak, Rachel Bastien, Patrick Sterkers, Yvon |
author_facet | Roux, Guillaume Ravel, Christophe Varlet-Marie, Emmanuelle Jendrowiak, Rachel Bastien, Patrick Sterkers, Yvon |
author_sort | Roux, Guillaume |
collection | PubMed |
description | PCR inhibition is frequent in medical microbiology routine practice and may lead to false-negative results; however there is no consensus on how to detect it. Pathogen-specific and human gene amplifications are widely used to detect PCR inhibition. We aimed at comparing the value of PCR inhibitor detection using these two methods. We analysed Cp shifts (ΔCp) obtained from qPCRs targeting either the albumin gene or the pathogen-specific sequence used in two laboratory-developed microbiological qPCR assays. 3152 samples including various matrixes were included. Pathogen-specific amplification and albumin qPCR identified 62/3152 samples (2.0%), and 409/3152 (13.0%) samples, respectively, as inhibited. Only 16 samples were detected using both methods. In addition, the use of the Youden's index failed to determine adequate Cp thresholds for albumin qPCR, even when we distinguished among the different sample matrixes. qPCR targeting the albumin gene therefore appears not adequate to identify the presence of PCR inhibitors in microbiological PCR assays. Our data may be extrapolated to other heterologous targets and should discourage their use to assess the presence of PCR inhibition in microbiological PCR assays. |
format | Online Article Text |
id | pubmed-6764677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-67646772019-10-12 Inhibition of polymerase chain reaction: Pathogen-specific controls are better than human gene amplification Roux, Guillaume Ravel, Christophe Varlet-Marie, Emmanuelle Jendrowiak, Rachel Bastien, Patrick Sterkers, Yvon PLoS One Research Article PCR inhibition is frequent in medical microbiology routine practice and may lead to false-negative results; however there is no consensus on how to detect it. Pathogen-specific and human gene amplifications are widely used to detect PCR inhibition. We aimed at comparing the value of PCR inhibitor detection using these two methods. We analysed Cp shifts (ΔCp) obtained from qPCRs targeting either the albumin gene or the pathogen-specific sequence used in two laboratory-developed microbiological qPCR assays. 3152 samples including various matrixes were included. Pathogen-specific amplification and albumin qPCR identified 62/3152 samples (2.0%), and 409/3152 (13.0%) samples, respectively, as inhibited. Only 16 samples were detected using both methods. In addition, the use of the Youden's index failed to determine adequate Cp thresholds for albumin qPCR, even when we distinguished among the different sample matrixes. qPCR targeting the albumin gene therefore appears not adequate to identify the presence of PCR inhibitors in microbiological PCR assays. Our data may be extrapolated to other heterologous targets and should discourage their use to assess the presence of PCR inhibition in microbiological PCR assays. Public Library of Science 2019-09-27 /pmc/articles/PMC6764677/ /pubmed/31560697 http://dx.doi.org/10.1371/journal.pone.0219276 Text en © 2019 Roux et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Roux, Guillaume Ravel, Christophe Varlet-Marie, Emmanuelle Jendrowiak, Rachel Bastien, Patrick Sterkers, Yvon Inhibition of polymerase chain reaction: Pathogen-specific controls are better than human gene amplification |
title | Inhibition of polymerase chain reaction: Pathogen-specific controls are better than human gene amplification |
title_full | Inhibition of polymerase chain reaction: Pathogen-specific controls are better than human gene amplification |
title_fullStr | Inhibition of polymerase chain reaction: Pathogen-specific controls are better than human gene amplification |
title_full_unstemmed | Inhibition of polymerase chain reaction: Pathogen-specific controls are better than human gene amplification |
title_short | Inhibition of polymerase chain reaction: Pathogen-specific controls are better than human gene amplification |
title_sort | inhibition of polymerase chain reaction: pathogen-specific controls are better than human gene amplification |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764677/ https://www.ncbi.nlm.nih.gov/pubmed/31560697 http://dx.doi.org/10.1371/journal.pone.0219276 |
work_keys_str_mv | AT rouxguillaume inhibitionofpolymerasechainreactionpathogenspecificcontrolsarebetterthanhumangeneamplification AT ravelchristophe inhibitionofpolymerasechainreactionpathogenspecificcontrolsarebetterthanhumangeneamplification AT varletmarieemmanuelle inhibitionofpolymerasechainreactionpathogenspecificcontrolsarebetterthanhumangeneamplification AT jendrowiakrachel inhibitionofpolymerasechainreactionpathogenspecificcontrolsarebetterthanhumangeneamplification AT bastienpatrick inhibitionofpolymerasechainreactionpathogenspecificcontrolsarebetterthanhumangeneamplification AT sterkersyvon inhibitionofpolymerasechainreactionpathogenspecificcontrolsarebetterthanhumangeneamplification |